Inspiratory Muscle Training Combined With General Exercise Training in COPD

NCT ID: NCT02392715

Last Updated: 2015-03-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-30

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic Obstructive Pulmonary Disease (COPD) is a frequent disease, with increasing prevalence. Pulmonary rehabilitation through general exercise training (GET) is a corner stone of COPD care. Inspiratory muscle training (IMT) as a stand-alone therapy decreases dyspnea and improves exercise capacity. Whether IMT combined with GET adds a supplementary benefit in the rehabilitation of COPD patients is however uncertain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective, parallel-group, randomized controlled trial

80 COPD patients will be randomized into two groups. One group will receive general exercise training combined with inspiratory muscle training, 3 times a week, for a total of 36 sessions. The other group will receive general exercise training combined with shame inspiratory muscle training, 3 times a week, for a total of 36 sessions.

We will assess the difference of improvement in exercise capacity between the 2 groups with the 6 minute walking test. We will also assess the difference of improvement in quality of life with St-George's respiratory questionnaire. Finally the difference of improvement in maximal inspiratory pressure will be determined.

Patients and investigators assessing the outcomes will be blinded to group allocation.

Written informed consent will be obtained from each subject. The data will be treated anonymously.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention cohort

36 sessions of 60 - 75 minutes with a frequency of 3x/week

30' endurance training, 15' strength training, 15' inspiratory muscle training with Threshold by Respironics

Inspiratory muscle training intensity: 15% of maximal inspiratory pressure (PiMax) during the first week. Then increment of 5% each session until 60% of PiMax after the first month. The PiMax will be reassessed after 12 and 24 sessions in order to readjust the 60% of PiMax.

Group Type EXPERIMENTAL

Inspiratory muscle training with Threshold by respironics

Intervention Type DEVICE

Inspiratory muscle training

15 minutes, 3x/weeks, 36 sessions

Intensity: 15% of PiMax during the first week. Then increment of 5% each session until 60% of PiMax after the first month. The PiMax will be reassessed after 12 and 24 sessions in order to readjust the 60% of PiMax.

Control cohort

36 sessions of 60 - 75 minutes with a frequency of 3x/week

30' endurance training, 15' strength training, 15' sham inspiratory muscle training with Threshold by Respironics

Sham inspiratory muscle training intensity : 5 centimeters of water (cmH20)

Group Type SHAM_COMPARATOR

Sham Inspiratory muscle training

Intervention Type DEVICE

with Threshold by respironics

15 minutes, 3x/weeks, 36 sessions

Intensity: 5 centimeters of water (cmH20)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Inspiratory muscle training with Threshold by respironics

Inspiratory muscle training

15 minutes, 3x/weeks, 36 sessions

Intensity: 15% of PiMax during the first week. Then increment of 5% each session until 60% of PiMax after the first month. The PiMax will be reassessed after 12 and 24 sessions in order to readjust the 60% of PiMax.

Intervention Type DEVICE

Sham Inspiratory muscle training

with Threshold by respironics

15 minutes, 3x/weeks, 36 sessions

Intensity: 5 centimeters of water (cmH20)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* COPD demonstrated by spirometry using Gold Criteria
* Patient referred by a pneumologist to the ambulatory pulmonary rehabilitation program at the Riviera-Chablais Hospital, Monthey
* Patient with maximal inspiratory pressure \< 60 cmH20
* Patient older than 40 years

Exclusion Criteria

* Orthopaedic or neurological troubles that could slant the 6 minute walking test
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hôpital Riviera-Chablais, Vaud-Valais

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stéphanie Vaudan

Stéphanie Vaudan, board-certified respiratory therapist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stéphanie Vaudan, BSc

Role: PRINCIPAL_INVESTIGATOR

[email protected]

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stéphanie Vaudan, BSc

Role: CONTACT

+41 24 473 18 99

Nicolas Garin, MD

Role: CONTACT

+ 41 24 473 80 75

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

003/15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

IMT in Hypercapnic Patients With COPD
NCT02914093 TERMINATED NA